Cancer immunotherapy and vaccine development have significantly improved the fight
against cancers. Despite these advancements, challenges remain, particularly in the clinical …

With the rapid growth of advanced nanoengineering strategies, there are great implications
for therapeutic immunostimulators formulated in nanomaterials to combat cancer. It is crucial …

Glioma is the most common intracranial malignant tumor, and the current main standard
treatment option is a combination of tumor surgical resection, chemotherapy and …

Triple-negative breast cancer (TNBC) is characterized by a high possibility of metastasis. M2-
like tumor-associated macrophages (TAMs) are the main components of the tumor …

Various cancer therapies have advanced remarkably over the past decade. Unlike the direct
therapeutic targeting of tumor cells, cancer immunotherapy is a new strategy that boosts the …

Cancer immunotherapy is currently one of the most attractive therapeutics against
hematological malignancies, but unfortunately, the outcomes remain unsatisfactory in most …

Abstract Background p16, p53, and proliferating cell nuclear antigen (pcna) genes play
significant roles in many chromatin modifications and have been found to be highly …

Immunomodulation is a powerful therapeutic approach that harnesses the body's own
immune system and reprograms it to treat diseases, such as cancer. Innate immunity is key …

Cancer is a leading cause of death worldwide. Nowadays, the therapies are inadequate and
spur demand for improved technologies. Rapid growth in nanotechnology and novel …

Recent advances in nanotechnology have offered novel ways to combat cancer. By utilizing
the reducing capabilities of Lactobacillus acidophilus, silver nanoparticles (AgNPs) are …